Abstract
Background
Alterations of the p53 tumor suppressor gene are the most commonly observed genetic abnormalities in many different types of human malignancies. The accumulation of mutant p53 often leads to the production of p53 antibody (p53-Ab) in the sera of patients with various cancers. To evaluate the clinical implications of serum p53-Abs in patients with gastric cancer, we compared p53-Abs with conventional tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen (CA)19-9.
Methods
Serum samples were obtained preoperatively from 40 patients with histologically confirmed gastric adenocarcinoma, including 28 (70%) patients in stage Ia. The serum p53-Abs were assessed by enzyme-linked immunosorbent assay, using a new version of a highly specific, quantitative p53-Abs Kit (MESACUP Kit II).
Results
p53-Abs were detected in 6 (15%) of 40 patients with gastric cancer, including 3 patients with early gastric cancer. Seven (17.5%) of the 40 patients were positive for CEA in serum. However, none of 7 patients with high CEA levels were positive for p53-Abs. No significant correlation of p53-Abs with patient age, sex, pathological parameters, tumor markers such as CEA and CA19-9, or poor survival (P = 0.116) was observed.
Conclusion
Although we employed the latest version of the p53-Abs Kit, the sensitivity of serum p53-Ab in gastric cancer patients was relatively low. No correlation was found between the presence of p53-Ab and the staging of cancer or survival. However, serum p53-Ab was detectable in patients with gastric cancer even in the early stages of disease. In addition, it may be independent of CEA and CA19-9.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
EP Diamandis (1992) ArticleTitleOncogenes and tumor suppressor genes: new biochemical tests Crit Rev Clin Lab Sci 29 269–305 Occurrence Handle1489520 Occurrence Handle1:CAS:528:DyaK3sXhsVCnu7s%3D
A Levine J Momand C Finlay (1991) ArticleTitleThe p53 tumor suppressor gene Nature 351 453–5 Occurrence Handle10.1038/351453a0 Occurrence Handle2046748 Occurrence Handle1:CAS:528:DyaK3MXksVaku7g%3D
T Soussi Y Legros R Lubin K Ory B Schlichtholz (1994) ArticleTitleMultifactorial analysis of p53 alteration in human cancer: a review Int J Cancer 57 1–9 Occurrence Handle8150526 Occurrence Handle1:STN:280:ByuB3c%2FoslA%3D
F Chang S Syrjanen K Syrjanen (1995) ArticleTitleImplications of the p53 tumor suppressor gene in clinical oncology J Clin Oncol 13 1009–22 Occurrence Handle7707100 Occurrence Handle1:STN:280:ByqB383ivF0%3D
D Lane S Benchimol (1990) ArticleTitlep53: oncogene or anti-oncogene? Genes Dev 4 1–8 Occurrence Handle2137806 Occurrence Handle1:CAS:528:DyaK3cXhtFaru78%3D
A Davidoff P Humphrey J Iglehart J Marks (1991) ArticleTitleGenetic basis for p53 overexpression in human breast cancer Proc Natl Acad Sci USA 88 5006–10 Occurrence Handle2052583 Occurrence Handle1:CAS:528:DyaK3MXksVehtrc%3D
LV Crawford DC Pim RD Bulbrook (1982) ArticleTitleDetection of antibodies against the cellular protein p53 in sera from patients with breast cancer Int J Cancer 30 403–8 Occurrence Handle6292117 Occurrence Handle1:STN:280:BiyD2MrptFQ%3D
FC Caron LF May H Mouriesse J Lemerle K Chandrasekaran P May (1987) ArticleTitlePresence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma Int J Cancer 39 185–9
K Angelopoulou EP Diamandis DJA Sutherland JA Kellen PS Bunting (1994) ArticleTitlePrevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers Int J Cancer 58 480–7 Occurrence Handle8056443 Occurrence Handle1:STN:280:ByuA3szptl0%3D
R Lubin B Schlichtholz JL Teillaud E Garay A Bussel C Wild et al. (1995) ArticleTitlep53 antibodies in patients with various types of cancer: assay, identification and characterization Clin Cancer Res 1 1463–9 Occurrence Handle9815945 Occurrence Handle1:STN:280:DyaK1M%2FjsV2lsQ%3D%3D
JP Peyrat J Bonneterre R Lubin L Vanlemmens J Fournier T Soussi (1995) ArticleTitlePrognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer Lancet 345 621–2 Occurrence Handle10.1016/S0140-6736(95)90523-5 Occurrence Handle7898180 Occurrence Handle1:STN:280:ByqB3crpsF0%3D
T Lethinen T Luostarinen J Dillner (1996) ArticleTitleSerum p53 accumulation and altered antibody response to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin Br J Haematol 93 104–10
MC Breveren von MC Hollstein HM Cawley VGM De Benedetti WP Bennett L Liang et al. (1996) ArticleTitleCirculating anti-p53 antibodies in oesophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors Cancer Res 56 4917–21
J Marxsen W Schmiegel C Roder R Harder H Juhl D Henne-Bruns et al. (1994) ArticleTitleDetection of the anti-p53 antibody response in malignant and benign pancreatic disease Br J Cancer 70 1031–4 Occurrence Handle7947080 Occurrence Handle1:STN:280:ByqD3svgtlE%3D
K Nakajima T Suzuki H Shimada H Hayashi A Takeda T Ochiai (1999) ArticleTitleDetection of preoperative serum anti-p53 antibodies in gastric cancer Tumor Biol 20 147–52 Occurrence Handle10.1159/000030057 Occurrence Handle1:STN:280:DyaK1M3jsVejsQ%3D%3D
GE Trivers HL Cawley VM DeBenedetti M Hollstein MJ Marion WP Bennett et al. (1995) ArticleTitleAnti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride J Natl Cancer Inst 87 1400–7 Occurrence Handle7658501 Occurrence Handle1:CAS:528:DyaK2MXoslKiu7g%3D
P Hammel B Boissier MT Chaumette P Piedbois N Rotman JC Kouyoumdjian et al. (1997) ArticleTitleDetection and monitoring of serum p53 antibodies in patients with colorectal cancer Gut 40 356–61 Occurrence Handle9135525 Occurrence Handle1:STN:280:ByiB1c7itFM%3D
JG Houbiers SH van der Burg LM van de Watering RA Tollenaar A Brand CJ van de Velde et al. (1995) ArticleTitleAntibodies against p53 are associated with poor prognosis of colorectal cancer Br J Cancer 72 637–41 Occurrence Handle7669574 Occurrence Handle1:CAS:528:DyaK2MXotV2ktLs%3D
Y Maehara Y Kakeji A Watanabe H Baba H Kusumoto S Kohnoe et al. (1999) ArticleTitleClinical implications of serum anti-p53 antibodies for patients with gastric carcinoma Cancer 85 302–8 Occurrence Handle10.1002/(SICI)1097-0142(19990115)85:2<302::AID-CNCR6>3.0.CO;2-6 Occurrence Handle10023696 Occurrence Handle1:STN:280:DyaK1M7ks1ejsw%3D%3D
P Würl F Weigmann A Meye M Fittkau U Rose D Berger et al. (1997) ArticleTitleDetection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance Scand J Gastroenterol 32 1147–51 Occurrence Handle9399397
CW Wu YY Lin GD Chen CW Chi DP Carbone JY Chen (1999) ArticleTitleSerum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade Br J Cancer 80 483–8 Occurrence Handle10408857 Occurrence Handle1:CAS:528:DyaK1MXitFersL4%3D
G Shiota M Ishida N Noguchi Y Takano K Oyama M Okubo et al. (1998) ArticleTitleClinical significance of serum p53 antibody in patients with gastric cancer Res Commun Mol Pathol Pharmacol 99 41–51 Occurrence Handle9523354 Occurrence Handle1:CAS:528:DyaK1cXhslamsbw%3D
H Shimada T Ochiai F Nomura (2003) ArticleTitleTitration of serum p53 antibodies in 1085 patients with various types of malignant tumors Cancer 97 682–9 Occurrence Handle10.1002/cncr.11092 Occurrence Handle12548611
AO Chan KM Chu SK Lam BC Wong KF Kwok S Law et al. (2003) ArticleTitleSoluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer J Clin Oncol 21 2288–93 Occurrence Handle10.1200/JCO.2003.08.078 Occurrence Handle12805328 Occurrence Handle1:CAS:528:DC%2BD2cXpsVKrs74%3D
M Juhasz MP Ebert HU Schulz C Rocken B Molnar Z Tulassay et al. (2003) ArticleTitleDual role of serum soluble E-cadherin as a biological marker of metastatic development in gastric cancer Scand J Gastroenterol 38 850–5 Occurrence Handle10.1080/00365520310003985 Occurrence Handle12940439 Occurrence Handle1:CAS:528:DC%2BD3sXmtVeltL8%3D
K Tanaka C Miki R Wakuda M Kobayashi H Tonouchi M Kusunoki (2004) ArticleTitleCirculating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma Scand J Gastroenterol 39 754–60 Occurrence Handle15513361 Occurrence Handle1:CAS:528:DC%2BD2cXnslantb4%3D
Y Kodera Y Yamamura A Torii K Uesaka T Hirai K Yasui et al. (1996) ArticleTitleThe prognosis value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer Am J Gastroenterol 91 49–53 Occurrence Handle8561143 Occurrence Handle1:STN:280:BymC2crivVU%3D
S Ishigami S Natsugoe S Hokita X Che K Tokuda A Nakajo et al. (2001) ArticleTitleClinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer J Clin Gastroenterol 32 41–4 Occurrence Handle10.1097/00004836-200101000-00010 Occurrence Handle11154168 Occurrence Handle1:STN:280:DC%2BD3M3kt1Kgtw%3D%3D
R Lubin G Zalcman L Bouchet J Tredaniel Y Legros D Cazals et al. (1995) ArticleTitleSerum p53 antibodies as early markers of lung cancer Nature Med 1 701–2 Occurrence Handle7585154 Occurrence Handle1:CAS:528:DyaK2MXms1Kgtr0%3D
G Zalcman B Schlichtholz J Tredaniel T Urban R Lubin I Dubois et al. (1998) ArticleTitleMonitoring of p53 auto antibodies in lung cancer during therapy: relationship to response to treatment Clin Cancer Res 4 1359–66 Occurrence Handle9626451 Occurrence Handle1:CAS:528:DyaK1cXktVWhsLw%3D
P Berloco F Russo F Cariola M Gentile P Giorgio ML Caruso et al. (2003) ArticleTitleLow presence of p53 abnormalities in H. pylori-infected gastric mucosa and in gastric adenocarcinoma J Gastroenterol 38 28–36 Occurrence Handle10.1007/s005350300003 Occurrence Handle12560919 Occurrence Handle1:CAS:528:DC%2BD3sXovFajtA%3D%3D
G Tan D Xing S Tan Q Chen (2004) ArticleTitleRapid and sensitive immunomagnetic-electrochemiluminescent detection of p53 antibodies in human serum J Immunol Methods 288 47–54 Occurrence Handle15183084
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shimizu, K., Ueda, Y. & Yamagishi, H. Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients. Gastric Cancer 8, 214–219 (2005). https://doi.org/10.1007/s10120-005-0337-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10120-005-0337-4